-
Biotech /Pharma Market Movers; (NYSE:BSX), (NASDAQ:BPAX), (OTCBB: UVFT), (NASDAQ: CELG)
Thursday, October 28, 2010 - 2:14pm | 1080Read More...Boston Scientific (NYSE: BSX) Agrees to Sell Neurovascular Business to Stryker; StockTrades Over 16 Millions Shares in Morning Trading Point Roberts, WA –October 28, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for...
-
Biotech/Pharma Stock Profile Update; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)
Wednesday, October 27, 2010 - 1:48pm | 1309Read More...Recent News; BioSante Pharmaceuticals Reports Positive LibiGel® Data Monitoring Committee Recommendation Point Roberts, WA, LINCOLNSHIRE, Ill –October 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com) reports the following updates for showcase biotech stock BioSante...
-
BPAX Reaches Key LibiGel® Safety Study Enrollment Target
Monday, October 18, 2010 - 12:28pm | 1399Read More...LINCOLNSHIRE, Ill. - October 18, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers...
-
BPAX Presents Update at North American Menopause Society Meeting
Tuesday, October 12, 2010 - 3:28pm | 1020Read More...LINCOLNSHIRE, Ill. - October 12, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) presented a LibiGel clinical study update at the 21st Annual Meeting of The North American Menopause Society (NAMS) on October 8, 2010, with more than 1,000 experts and practitioners in...
